Is Day-4 morula biopsy a feasible alternative for preimplantation genetic testing?
<h4>Objective</h4>To assess the efficacy and clinical outcome of PGT-M undertaken on Day-3, Day-4 and Day-4 "delayed" embryos that were unsuitable for biopsy on Day-3.<h4>Design and setting</h4>Cohort-historical study of all consecutive patients admitted to the IVF-...
Main Authors: | Raoul Orvieto, Baruch Feldman, Marine Wiesel, Hagit Shani, Adva Aizer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0238599 |
Similar Items
-
Can expelled cells/debris from a developing embryo be used for PGT?
by: Adva Aizer, et al.
Published: (2021-08-01) -
P557: Preimplantation genetic diagnosis for facioscapulohumeral muscular dystrophy
by: Hagit Shani, et al.
Published: (2023-01-01) -
Is the hypothesis of preimplantation genetic screening (PGS) still supportable? A review
by: Norbert Gleicher, et al.
Published: (2017-03-01) -
Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers
by: Moran Friedman-Gohas, et al.
Published: (2021-07-01) -
Biopsy of human morula-stage embryos: outcome of 215 IVF/ICSI cycles with PGS.
by: Elena E Zakharova, et al.
Published: (2014-01-01)